NanoViricides Inc. (NNVC)

[changes_iv]

IT HAS BEEN 22 DAYS OF 60---ANY UPDATES FROM YOUR GOVERNMENT?

Contained? NYC Department Of Health Actively Monitoring 357 Individuals For Ebola

The good news is that New York's first Ebola patient, Dr. Spencer, is "showing improvement." The bad news is:

*NYC: 357 INDIVIDUALS ACTIVELY MONITORED AS OF NOV. 5

Contained indeed and "hard to catch." Perhaps that explains why Obama just asked for $6.2 billion to manage this monster.

*JOINT EBOLA UPDATE FROM NYC DOHMH AND HHC
*NYC: EBOLA PATIENT IN BELLEVUE CONDITION IS STABLE
*NYC: EBOLA PATIENT IN BELLEVUE CONTINUES TO SHOW IMPROVEMENT
*HHC CITING ONE PERSON IN QUARANTINE DUE TO CONTACT WITH SPENCER
*NYC: 357 INDIVIDUALS ACTIVELY MONITORED AS OF NOV. 5
*NYC: 1 NOW SUBJECT TO DIRECT ACTIVE MONITORING DUE TO SPENCER

http://www.zerohedge.com/news/2014-11-05/contained-nyc-department-health-actively-monitoring-357-individuals-ebola

Ebola accelerates in Sierra Leone with 900% higher transmission rate

(NaturalNews) Things have been relatively quiet on the Ebola front here in the U.S. this past week, with 11 days and counting (as of this writing) since the last confirmed case of the disease was announced. But the situation is hardly as rosy in Sierra Leone, where an Africa Governance Initiative (AGI) report says Ebola is now spreading at a 900 percent faster rate than two months ago.

In early September, the official number was 1.3 new cases of Ebola per day in Sierra Leone, one of the three "ground zero" countries that has been most ravaged by the virus. Now, that number has escalated to 12 new cases per day in the rural areas surrounding Freetown, the country's capital, representing a more than nine-fold increase.

http://www.naturalnews.com/047547_Ebola_transmission_rate_Sierra_Leone.html

Obama Requests $6 Billion for Ebola

President Obama is asking Congress for just over $6 billion in emergency funding to combat Ebola in West Africa and protect Americans from the virus in the United States, an administration official said Wednesday.

The request comes just after the midterm congressional elections on Tuesday in which Republicans took control of the Senate, dealing devastating losses to Democrats across the country and a rebuke to Mr. Obama that will complicate his efforts to advance his agenda.

The White House described the proposal as a chance for collaboration between the president and Capitol Hill.
Continue reading the main story
Related Coverage

“This is an opportunity for Congress and this administration to continue our work together to provide the additional resources needed through appropriations efforts in order to be responsive to the resource needs on the ground and here at home,” said a White House budget office official, speaking on the condition of anonymity to discuss details of the request before a formal announcement, made later on Wednesday afternoon.

Most of the money — more than $4.5 billion — would be for immediate response efforts, and an additional $1.5 billion would go into a contingency fund “to ensure that there are resources available to meet the evolving nature of the epidemic,” the official said.

http://www.nytimes.com/2014/11/06/us/politics/obama-to-ask-congress-for-6-billion-to-fight-ebola.html?_r=0

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”), a nanomedicine company developing anti-viral drugs, announced today that it has executed a CRADA (Collaborative Research and Development Agreement for Material Transfer) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). Certain novel anti-Ebola nanomedicine drug candidates recently developed by the Company will be evaluated by USAMRIID scientists in their BSL-4 facilities for activity against the deadly Ebola virus under this agreement.

"We are very happy to restart our collaboration with USAMRIID for developing an effective drug against the deadly Ebola virus," said Dr. Eugene Seymour, MD, MPH, CEO of NanoViricides, Inc., adding, "We intend to ship the samples as soon as the synthesis of the new drug candidates is completed." ~ Oct 27, 2014
.
.
.
NanoViricides undertook the extreme challenge of developing a drug to combat this disease in a "war-like" timeline. We believe that we can develop an effective drug rapidly compared to other approaches, because of the inherent strength of our nanoviricides® platform technology.

The Company has recently developed and is now synthesizing test quantities of its novel nanoviricide drug candidates against Ebola that it believes could lead to a successful therapeutic. These drug candidates are designed to mimic the host cell receptor onto which the Ebola virus binds to cause an infection. The site at which the virus binds does not change, in spite of mutations. Thus the Company believes that its drug candidates would continue to work in spite of field mutations in the virus. This is unlike vaccines, antibodies, siRNA, antisense, and several other therapeutic modes, which a virus can readily overcome due to mutations it acquires in the field.

http://www.nanoviricides.com/press%20releases/2014/NanoViricides,%20Inc.%20Signs%20CRADA%20for%20Material%20Transfer%20with%20USAMRIID%20for%20Evaluating%20Its%20Anti-Ebola%20Drug%20Candidates.html

EbolaCide2 - Plan of attack
Re: USAMRIID

Corinne (Scully) is gone and Gene (Olinger) is at the NIH virology labs

I'm in touch with Gene and would love to work with him.

We're shooting for a mid-November ship date but that's completely dependent on completing the synthesis of all the variants. Usually we make 8 variants, send them for testing, take the best two, expand them and make another eight.

This time, we're making many more and they'll all be tested during the same pass to save time. If this works as we hope, I want to get EbolaCide to Africa ASAP!

EUGENE SEYMOUR - Chief Executive Officer & Director
October 31, 2014

http://www.siliconinvestor.com/subject.aspx?subjectid=55797